Literature DB >> 10219709

Uses and misuses of the new pharmacotherapy of obesity.

G A Bray.   

Abstract

The worldwide epidemic of obesity has made the development of effective treatment ever more urgent. Appropriate use of medication for the treatment of obesity may benefit patients at risk for developing diabetes, hypertension, coronary artery disease, osteoarthritis or gall bladder disease. In addition, with the appearance of very safe medications, short-term treatment for the relief of the stigma associated with obesity may also be valuable. The currently available medications for obesity work either by reducing fat digestion or by acting on receptor systems in the brain. Both have potential side-effects, but may be useful alone or in combination. The expansion of knowledge about the control of obesity offers the hope that many new agents will become available over the next decade.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10219709     DOI: 10.3109/07853899909019257

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  2 in total

Review 1.  Use of sibutramine and other noradrenergic and serotonergic drugs in the management of obesity.

Authors:  D H Ryan
Journal:  Endocrine       Date:  2000-10       Impact factor: 3.925

Review 2.  Erectile dysfunction and central obesity: an Italian perspective.

Authors:  Giovanni Corona; Giulia Rastrelli; Sandra Filippi; Linda Vignozzi; Edoardo Mannucci; Mario Maggi
Journal:  Asian J Androl       Date:  2014 Jul-Aug       Impact factor: 3.285

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.